| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
Dipartimento di Biologia e Patologia Cellulare e Molecolare (M.I., V.A., A.C., T.D.M., G.R., M.V.), Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica (G.F.), e Cattedra di Nefrologia (M.A.), Università Federico II, 80131 Naples, Italy; and Centro di Endocrinologia ed Oncologia Sperimentale "G. Salvatore" (C.M., G.R.), Consiglio Nazionale delle Ricerche, 80131 Naples, Italy
Address all correspondence and requests for reprints to: Mario Vitale, M.D., Dipartimento di Biologia e Patologia Cellulare e Molecolare, Via S. Pansini 5, 80131 Napoli, Italy. E-mail: mavitale{at}unina.it.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In a number of different cell systems, the first signaling event following integrin clustering is the phosphorylation of the focal adhesion tyrosine kinase pp125FAK (19). A prototypical model of the pathway generated by cell adhesion leading to cell proliferation postulates that pp125FAK phosphorylation provides binding sites for the adapter molecules Shc and Grb2. They in turn recruit the guanine-nucleotide exchange factor Sos to the plasma membrane and activate p21 Ras (20, 21). Ras then activates the serine-threonine kinase Raf-1 that in turn activates the extracellular signal-related kinase (MEK) and MAPK. However, a number of studies argue against a role for pp125FAK in MAPK activation because inhibition of pp125FAK by a dominant negative truncated focal adhesion kinase (FAK) in fibroblast failed to block MAPK activation (22). The role of pp125FAK is complicated by the fact that its activation can play a critical role in integrin signaling controlling the activation of multiple MAPK family members such as the p44/p42 MAPK/ERK and the c-Jun NH2-terminal kinase through divergent signaling pathways. Besides the activation of p44/p42MAPK, pp125FAK phosphorylation induced activation of c-Jun NH2-terminal kinase through an alternative route involving paxillin and the small GTP-binding proteins of the
family (17) in the same cell system. Moreover, additional studies with a dominant negative Raf provided evidences in favor of the existence of a Ras-independent pathway of MAPK activation induced by integrins (23). The immediate phosphorylation of the focal adhesion components is not the only event elicited by integrin activation, as increase of intracellular calcium concentration, variations of intracellular pH, and phosphatidylinositol 3-kinase (PI3K) activation has been observed on cell attachment to ECM or binding of antiintegrin antibodies to platelets, macrophages, neutrophils, osteoclasts, and embryonic stem cells (24, 25, 26). Our study demonstrates that in thyroid cells, adhesion to FN regulates proliferation through the p21 Ras/MAPK pathway, whereas cell survival is mediated by PI3K.
| Materials and Methods |
|---|
|
|
|---|
The TAD-2 cell line, obtained by Simian virus 40 infection of human fetal thyroid cells was generously donated by Dr. T. F. Davies (Mount Sinai Hospital, New York, NY) and cultured in a 5% CO2 atmosphere at 37 C in DMEM (4.5 g glucose) and 10% fetal calf serum (FCS) (27). Medium was changed every 34 d. Cells were detached by 0.5 mM EDTA in calcium- and magnesium-free PBS with 0.05% trypsin. When needed, the cells were serum starved in 0.5% BSA and DMEM for 1218 h before stimulation.
To obtain a FN or BSA coating, cell culture plates were filled with the appropriate FN (Collaborative Research, Bedford, MA) or BSA (Sigma, St. Louis, MO) dilution in PBS. After overnight incubation at 4 C, FN was removed, and the plates were washed with PBS and stored at 4 C. Coexpression of a dominant negative Ras (RasN17) gene and green lantern fluorescent protein (GFP) in TAD-2 cells was induced by cotransfecting pRSV-RasN17 and pEGFP (CLONTECH Laboratories, Inc., Palo Alto, CA) expression vectors with LipofectAMINE reagent (Life Technologies, Inc., Rockville, MD) according to manufacturer instructions. Twenty-four hours after transfection, the percentage of GFPexpressing cells was determined by flow cytometry using a FACScan (Becton Dickinson and Co., Mountain View, CA). The transfection efficiency ranged from 8287%.
Cell cultures from normal thyroids were prepared as previously described by collagenase digestion (1) and cultured in a 5% CO2 atmosphere at 37 C, in F-12 medium supplemented with 10% FCS, with 1 mU/ml bovine thyreotropin (Sigma). The cells were used after 3 d.
[3H]thymidine incorporation and proliferation assay
To determine the DNA synthesis, cells were plated in DMEM, 0.5% BSA, 0.5µCi [3H]thymidine in 24-well plates coated with FN. After 24 h, the plates were gently washed with PBS avoiding cell loss and then with 10% trichloroacetic acid (TCA) and incubated 10 min with 20% TCA at 4 C. TCA was removed and cells were lysed with 0.2% SDS for 15 min at 4 C. Lysates were then resuspended in 5 ml scintillation fluid and counted in a ß-counter (Beckton Dickinson). To determine the mitogenic effect of FN, cells were plated in DMEM and 0.5% BSA in 24-well plates coated with FN. After 48 h, the cells were detached with trypsin and counted with a hemocytometer.
Estimation of apoptosis
Cytofluorimetric estimation of cell death was performed as follows: Floating cells were collected, washed in cold PBS, added to adherent cells, and trypsinized. Cells were washed again in PBS and fixed in 70% cold ethanol for 30 min. Ethanol was removed by two PBS washes, and cells were incubated in PBS, 50 µg/ml propidium iodide, 10 µg/ml ribonuclease A, and deoxyribonuclease-free overnight at 4 C. Cells were then analyzed by flow cytometry using a FACScan, and hypodiploid cells were counted. Annexin V assay for determination of early apoptosis was performed as follows: cells were washed twice with cold PBS, resuspended in 10 nM HEPES (pH 7.4), 140 mM NaCl, 2.5 mM CaCl2, and incubates for 15 min at room temperature with Annexin V-fluorescein conjugated (PharMingen, San Diego, CA) and 5 µg/ml propidium iodide. Cell were analyzed within 1 h by flow cytometry. The FN-integrin-binding inhibitor arginine-glycine-aspartic acid (RGD)-containing peptide (Gly-Arg-Gly-Asp-Ser-Pro) was purchased from Telios (San Diego, CA).
Western blot analysis and antibodies
Serum-starved cells (1 x 106) were plated on FN-coated Petri dishes in the presence and absence of serum. At variable times they were lysed in RIPA buffer [50 mM Tris-HCl (pH 8.0), 5 mM EDTA, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mM NaF, 5 mM EGTA, 10 mM sodium pyrophosphate, 1 mM phenylmethylsulfonyl fluoride]. A mouse monoclonal antibody was used to immunoprecipitate FAK or Paxillin (Transduction Laboratories, Inc., Lexington, KY) from 1 mg total lysate. The immunoprecipitates were then resolved by SDS-PAGE. Alternatively, the cells (3 x 105) were lysed in Laemmly buffer [125 mM Tris (pH 6.8), 5% glycerol, 2% SDS, 1% ß-mercaptoethanol, and 0.006% bromophenol blue] and resolved by SDS-PAGE. Proteins were then transferred to a nitrocellulose membrane (Immobilon P, Millipore Corp., Bedford, MA). Membranes were blocked by 5% nonfat dry milk, 1% ovalbumin, 5% FCS, and 7.5% glycine, and after three washes, the membranes were incubated for 1 h at 4 C with 0.5 µ/ml mouse monoclonal or rabbit polyclonal primary antibodies in PBS. After three washes filters were incubated for 1 h at 4 C with a horseradish peroxidase-conjugated antimouse secondary antibody. After a final wash, protein bands were detected by an enhanced chemiluminescence system (ECL) (Amersham Pharmacia Biotech, Rainham, UK). For quantitation, relative intensities of hybridization signals were measured at 560 nm with a gel scan apparatus (PDI, Upper Saddle River, NJ). Mouse monoclonal antibodies to Grb-2, p42 MAPK, and phospho-p44/p42 MAPK were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
p21 Ras activity assay
Ras activity was assayed by affinity precipitation using a Ras activation assay kit (Upstate Biotechnology, Inc., Lake Placid, NY). Briefly, 4 x 106 cells were plated on FN-coated plates and stimulated for 15 min as previously described. Cells were then lysed with MLB buffer [125 mM HEPES (pH 7.5), 750 mM NaCl, 5% Igepal CA630, 50 mM MgCl2, 5 mM EDTA, and 10% glycerol] and incubated with 5 µl of a 50% slurry of Raf-1 RBD (Ras-binding domain peptide) for 30 min at 4 C. The beads were then boiled in reducing sample buffer, and adsorbed proteins were resolved by electrophoresis, transferred to nitrocellulose, and probed with a monoclonal anti-Ras (1 µg/ml) (MLB, Raf-1 RBD, and anti-Ras were included in a Ras activation assay kit, Upstate Biotechnology, Inc.). Proteins were visualized using a horseradish peroxidase-conjugated secondary antibody and ECL.
p44/p42MAPK activity
Cells were stimulated as described at 37 C for 15 min. Cells were then washed twice with ice-cold PBS, homogenized in RIPA buffer, and 0.5 mg of clarified cellular extract was immunoprecipitated in 1 ml RIPA buffer at 4 C for 1 h using an antibody to p44MAPK (Santa Cruz Biotechnology, Inc.) and protein A-agarose beads (Santa Cruz Biotechnology, Inc.): The beads were then washed once with 1 ml RIPA buffer and twice with 1 ml kinase buffer [20 mM HEPES (pH 7.0), 10 mM MgCl2 1 mM dithiotreithol]. Samples were then resuspended in 40 µl kinase buffer with 0.25 mg/ml myelin basic protein (MBP), 20 µM ATP, and 20 µCi/ml
[32P]ATP and incubated at 30 C for 15 min. The reaction was quenched with Laemmly buffer, and proteins were separated through a 420% polyacrylamide/Tris glycine gel. Radioactive-phosphorylated MBP on dried gels was quantified by PhosphorImager (Molecular Dynamics, Inc., Uppsala, Sweden).
PI3K activity
Cells were lysed for 40 min at 4 C in 50 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1% Nonidet P-40, 10 mM EDTA, 10 mM Na4P207, 2 mM NaVO4, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 100 mM NaF, and 1 mM phenylmethylsulfonyl fluoride. Total amount of proteins in each sample was determined. PI3K activity was determined in immunoprecipitated as described (28). Briefly, 0.5 mg cell lysates were incubated with polyclonal antibodies to p85 preadsorbed to protein G-Sepharose beads for 3 h at 4 C. Pellets were then washed in PBS containing 1% (vol/vol) NP-40 and 0.2 mM, NaVO4, then in 100 mM Tris-HCl (pH 7.4) supplemented with 500 mM LiCl and 0.2 mM NaVO4, and finally in 10 mM Tris-HCl (pH 7.4), 100 mM NaCl, 1 mM EDTA, and 0.2 mM NaVO4. Pellets were further resuspended in 40 mM HEPES (pH 7.4) and 20 mM MgCl2, and the kinase reaction was initiated by addition of phosphatidylinositol (0.2 mg/ml) and 75 µM
[32P]ATP (7000 Ci/mol) and performed for 20 min at room temperature. The reaction was stopped by addition of 4 M HCl, and the phosphoinositides were extracted with a methanol-chloroform (vol/vol) mix. Finally, phospholipids were separated by thin-layer chromatography and visualized and quantified by PhosphorImager (Molecular Dynamics, Inc.).
Statistical analysis
Results are presented as the mean ± SD. Standard deviations less than 10% are not reported in the diagrams. Statistical analysis was performed by using the t test. The level of significance was set at P less than 0.05.
| Results |
|---|
|
|
|---|
[3H]thymidine incorporation was used to measure the DNA synthesis in TAD-2 cells cultured in serum-free medium on immobilized FN for 24 h (Fig. 1A
). To coat 24-well flat-bottom microtiter plates with FN, the plates were incubated overnight with PBS containing FN at a concentration ranged 0.1100 µg/ml. In the control samples, in the absence of immobilized FN, [3H]thymidine incorporation was very poor. The presence of FN coating induced a concentration-dependent increase in [3H]thymidine incorporation reaching a 3.8-fold at 10 µg/ml FN. To test the ability of FN to induce proliferation, TAD-2 cells were cultured in DMEM without serum, with or without FN coating, or in 10% FCS (Fig. 1B
). The number of adherent cells was determined by a hemocytometer after 3 h and then daily. Maximum cell proliferation was achieved in the presence of serum (approximately 69 h of doubling time), whereas in serum-free cultures without FN coating, the cell number remained unchanged. In serum-free cultures with FN coating, TAD-2 cells actively proliferated with a doubling time of 92 h.
|
After serum starvation in 0.5% BSA and DMEM for 1218 h, TAD-2 cells were harvested by trypsin and left to deposit onto 10 µg/ml FN-coated plates. Then, the cells were recovered, lysed, and pp125FAK and paxillin immunoprecipitated by specific monoclonal antibodies. Proteins were separated by electrophoresis on a 10% polyacrylamide gel and transferred to a nitrocellulose membrane. Total and phosphorylated FAK and paxillin were evidenced by specific antibodies and the antiphosphotyrosine antibody pY-20 (Fig. 2
). Cell attachment to FN-induced FAK phosphorylation as early as 15 min. This phosphorylation was sustained for at least 90 min. In addition, paxillin phosphorylation was induced by adhesion to immobilized FN. Paxillin phosphorylation started later than FAK phosphorylation and displayed a peak activation at 30 min that was sustained for 90 min.
|
|
We determined whether FN stimulation induces p21 Ras activation. Based on the ability of activated p21 Ras to bind Raf, extracts from cells stimulated by 10% FCS or FN for 15 min were incubated with Raf-1 RBD-conjugated agarose beads to allow the binding to activated Ras. Adsorbed Ras was then recovered from the beads and visualized by Western blot on a 12% polyacrylamide gel with anti-Ras antibody (Fig. 4A
). The binding to FN induced a strong increase of activated p21 Ras, although lower than that induced by FCS stimulation. Because the activation of p44/p42MAPK (ERK1/2) is a pivotal event of the Ras signal pathway leading to cell proliferation, we determined whether this kinase was phosphorylated and activated by cell attachment to FN. Serum-starved cells were seeded onto FN-coated plates in serum-free medium or untreated plates in the presence of 10% FCS for the appropriate time and lysed. Cell extracts were analyzed by Western blot with anti-p44MAPK to visualize the protein and with antiphosphothyrosine-p44/p42MAPK to visualize the activated kinase (Fig. 4B
). Both FCS and immobilized FN induced p44/p42MAPK phosphorylation. MAPK activation by FN was confirmed by in vitro incorporation of radioactive ATP into MBP. MAPK was immunoprecipitated by a specific antibody from cell extracts and incubated with
[32P]ATP and MBP. The reaction mixture was resolved on SDS-PAGE, and radioactive MBP was detected by autoradiography (Fig. 4C
). Strong MAPK activation was induced by FCS and attachment to FN.
|
The effect of integrin activation by FN on PI3K enzymatic activity was evaluated at different time points (Fig. 5
). TAD-2 cells were starved from FCS for 12 h, trypsinized, and retained in suspension for 1 h in plates coated with a thin layer of 2% agarose. Then, the cells were seeded onto plates coated by overnight incubation with 10 µg/ml FN or 1 mg/ml BSA solution. Serum starvation and 1-h suspension were necessary to decrease the background activity of PI3K. The enzyme was immunoprecipitated by antibodies anti-p85 regulative subunit and incubated with phosphatidylinositol and
[32P]ATP, and finally generation of radioactive phospholipids were analyzed by thin-layer chromatography. PI3K activity remained unchanged after 60 min in BSA-coated plates, whereas increase of PI3K enzymatic activity was observed on FN stimulation. PI3K activation was completely inhibited in the presence of 10 µM LY294002 in the culture medium.
|
FN-induced DNA synthesis and cell proliferation were evaluated in the presence of inhibitors of Ras and MAPK-activating kinase (MAPKK). The cells were transiently transfected with a control plasmid (GFP) alone or with a dominant-negative Ras expression vector (RasN17) and serum starved for 24 h. The cells were then seeded in serum-free medium onto 10 µg/ml FN-coated plates. GFP-transfected cells were alternatively treated with or without 40 µM PD98059, a molecular inhibitor of MAPKK. Then, [3H]thymidine incorporation was evaluated after 24 h (Fig. 6A
), and the cell number was determined after 48 h (Fig. 6B
) of culture. Both DNA synthesis and cell proliferation were inhibited almost completely by RasN17 and PD98059, thus demonstrating that Ras/MAPK pathway is needed for FN-induced growth in TAD-2 cells. The effect of PD98059 on cell cycle was evaluated also in primary cultures of thyroid cells by FACScan analysis. Three-day-old primary cultures from normal thyroids were plated onto FN-coated plates and cultured for 48 h in serum-free medium with PD98059 or left untreated. Then, the cells were collected, stained with propidium iodide, and analyzed by FACScan (Fig. 6C
). Primary cultures of thyroid cells are characterized by slow and limited growth. The number of cells in S-phase decreased fom 1314% in untreated cells to 13% after PD98059 treatment, demonstrating that MAPKK is necessary to FN-stimulated cell growth also in primary cultures.
|
We previously showed that denied adhesion to ECM rapidly induced apoptosis in thyroid cells (2). To evaluate the role of integrin signaling in cell survival and growth, we investigated the effect of the inhibition of PI3-K and Ras/MAPK pathway to TAD-2 cells. Cells transfected with GFP alone or in combination with RasN17 were seeded in serum-free medium onto 10 µg/ml FN-coated plates. Alternatively, cells were plated on FN and treated with 40 µM PD98059, 10 µM LY294002, and 50 nM wortmannin (not shown) or 100 µg/ml of the FN integrin-binding inhibitor RGD-containing peptide. After 48 h, GFP- and RasN17-transfected cells and cells treated with PD98059 were adherent and displayed a flattened shape, whereas cells treated with RGD-containing peptides or the PI3K inhibitor were nonadherent and displayed a spherical shape. Both adherent and floating cells were collected and apoptosis was estimated by flow cytometric analysis. Hypodiploid cells were observed only in the presence of LY294002 and RGD-containing peptides, whereas they were absent in the presence of PD98059 and in RasN17-transfected cells (Fig. 7A
). The percentages of hypodiploid cells induced by 48 h of treatment with increasing concentrations of PD98059 and LY294002 were calculated by flow cytometry (not shown). Increasing concentrations of PD98059 up to 50 µM did not induce cell death, whereas LY294002 demonstrated a dose-dependent effect, inducing cell death in 68% of the cells at 10-µM concentration. Because loss of fragmented DNA is a late apoptotic and necrotic phenomenon, plasma membrane phosphatidylserine exposure, an early and specific apoptotic phenomenon, was analyzed by annexin V-binding assay (Fig. 7B
). Annexin V-binding assay demonstrated apoptosis in LY294002- and RGD-treated cells but not in cells treated with PD98059 (not shown). The effect of PI3K and MAPKK inhibition on survival was studied also in thyroid primary cultures. Three-day-old primary cultures from normal thyroids were plated onto FN and left untreated or were cultured in serum-free medium with 40 µM PD98059 or 10 µM LY294002 for 72 h. Then, the cells were collected, stained with propidium iodide, and analyzed by FACScan (Fig. 7C
). While MAPKK inhibiton by PD98052 did not produce hypodiploid cells, PI3K inhibition induced cellular loss of DNA. The analysis by annexin V/propidium iodide demonstrated that cell death was due to apoptosis (not shown). These data confirm in primary cultures the results obtained in TAD-2 cells and extends the role of PI3K to normal thyroid cells.
|
| Discussion |
|---|
|
|
|---|
6ß4, laminin/collagen receptor
1ß1, and FN/vitronectin receptors
5ß1 and
vß3 activate p44/p42MAPK through the p21 Ras signaling and the assembly of Shc/Grb-2/Sos (21, 29, 30). In our study, FN binding to integrins induced FAK and paxillin phosphorylation, inducing the formation of the FAK/Grb-2/Sos complex, thus confirming the involvement of these upstream components of the integrin pathway also in the thyroid cell. This pathway initiates with FAK activation and proceeds to SH2-domain adapter proteins, guanine nucleotide exchange factors, Ras, Raf-1, MAPKK, and finally to MAPK. However, the direct involvement of FAK, the first element of this kinase cascade, is not certain, and alternative pathways leading to MAPK activation without FAK involvement have been proposed (29). In our cell system, FAK is phosphorylated following adhesion to FN. Nevertheless, its role in the activation of the signal pathway leading to cell proliferation has not been documented, and further direct experiments are needed to address this question. The proposed FAK-independent routes from integrins to MAPK include direct involvement of Src kinase or the membrane protein caveolin, which both interact with Shc (31).
|
In several other receptor-generated signal pathways, Ras and other kinases provide costimulatory signals that together lead to MAPK activation. Besides Ras, PI3K activity is necessary to phosphorylate Raf-1 for activation of MAPK by insulin, IGF-I, IL-2 and -8, PDGF, vasopressin, T-cell receptor, and adrenergic receptor, and several other kinases can phosphorylate Raf-1 (Src, protein kinases A and C, Akt) (33, 34, 35, 36, 37, 38). The role of PI3K as a costimulatory factor also was demonstrated in the integrin signal pathway, as attenuation of integrin-dependent MAPK activation by PI3K inhibition was demonstrated in COS 7 cells (39). Following integrin-FN binding in these cells, PI3K regulates the phosphorylation of Raf-1 Ser338 through the serine/threonine kinase Pak (40). By this costimulatory mechanism, integrins can simultaneously generate and modulate a growth stimulus. The possibility that other hormones and growth factors operate a similar control mechanism in the thyroid cell is worthy of thorough investigation.
Although inhibition of integrin activation by RGD- containing peptides induced cell death (anoikis), inhibition of the Ras/MAPK pathway did not affect thyroid cell survival, but inhibition of PI3K induced apoptosis. PD98059 and LY294002 or wortmannin induce apoptosis in the liver cancer cells HepG2 and vascular smooth muscle cells, indicating that both the MAPKK/MAPK and the PI3K pathways are required for survival in these cells (41, 42). However, inhibition of Ras or MAKK in PC12 cells does not promote apoptosis, suggesting that the role of the Ras/MAPK pathway in survival is cell type and context specific. In TAD-2 cells, RasN17 and PD98059 induced growth arrest but did not induce apoptosis, indicating that the Ras/MAPK pathway is essential for proliferation but is not required for survival. Although the Ras/MAPK pathway is not necessary for TAD-2 cell survival, it can have synergistic effects with other signaling, protecting the cell from anoikins. Ras oncogene in transformed epithelial cells can mimic the protective effect of matrix through a direct interaction with the catalytic p110 subunit of PI3K or downstream cytochrome c release from the mitochondria at a point distinct from PI3K/Akt (43, 44, 45). Evidences of coexisting antiapoptotic pathways are provided by the demonstration that growth factors inhibit BAD- mediated apoptosis through BAD phosphorylation in tree serine residues, Ser155, Ser136, and Ser112, by protein kinase A or PI3K (46). Thus, although the Ras/MAPK pathway may only marginally participate in FN-dependent survival, PI3K plays a pivotal role in integrin-dependent cell survival in thyroid cell.
Altered integrin expression or abnormal modulation of integrin signalings could lead to unregulated proliferation sustained by ECM or integrins in pathological situations such as neoplastic transformation (47). Indeed, an altered pattern of integrin expression has been demonstrated in thyroid neoplastic cells, and its role in tumor growth must be investigated (48).
| Acknowledgments |
|---|
| Footnotes |
|---|
Abbreviations: ECL, Enhanced chemiluminescence; ECM, extracellular matrix; FAK, focal adhesion kinase; FCS, fetal calf serum; FN, fibronectin; GFP, green lantern fluorescent protein; MAPKK, MAPK-activating kinase; MBP, myelin basic protein; PI3K, phosphatidylinositol 3-kinase; RBD, Ras-binding domain peptide; RGD, arginine-glycine-aspartic acid; TAD-2, immortalized human thyrocyte; TCA, trichloroacetic acid.
Received May 17, 2002.
Accepted September 25, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. Zheng, J. D. Ritzenthaler, J. Roman, and S. Han Nicotine Stimulates Human Lung Cancer Cell Growth by Inducing Fibronectin Expression Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 681 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fujarewicz, M. Jarzab, M. Eszlinger, K. Krohn, R. Paschke, M. Oczko-Wojciechowska, M. Wiench, A. Kukulska, B. Jarzab, and A. Swierniak A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping Endocr. Relat. Cancer, September 1, 2007; 14(3): 809 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Illario, A. L. Cavallo, S. Monaco, E. Di Vito, F. Mueller, L. A. Marzano, G. Troncone, G. Fenzi, G. Rossi, and M. Vitale Fibronectin-Induced Proliferation in Thyroid Cells Is Mediated by {alpha}v{beta}3 Integrin through Ras/Raf-1/MEK/ERK and Calcium/CaMKII Signals J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2865 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marconi, P. Atzei, C. Panza, C. Fila, R. Tiberio, F. Truzzi, T. Wachter, M. Leverkus, and C. Pincelli FLICE/caspase-8 activation triggers anoikis induced by {beta}1-integrin blockade in human keratinocytes J. Cell Sci., November 15, 2004; 117(24): 5815 - 5823. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Illario, A. L. Cavallo, K. U. Bayer, T. Di Matola, G. Fenzi, G. Rossi, and M. Vitale Calcium/Calmodulin-dependent Protein Kinase II Binds to Raf-1 and Modulates Integrin-stimulated ERK Activation J. Biol. Chem., November 14, 2003; 278(46): 45101 - 45108. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |